DHI 📈 DR Horton - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US23331A1097
DHI: Single-Family Homes, Attached Homes, Mortgage Services, Title Insurance
D.R. Horton, Inc. is a prominent homebuilding company with operations spanning across the United States, covering regions such as the East, North, Southeast, South Central, Southwest, and Northwest. The company's core business involves acquiring and developing land, followed by the construction and sale of residential homes. With a significant presence in 125 markets across 36 states, D.R. Horton offers a range of housing options under its brand name, including single-family detached homes and attached homes like townhomes, duplexes, and triplexes.
Beyond its core homebuilding activities, D.R. Horton provides a suite of services designed to facilitate the homebuying process. This includes mortgage financing services, which help buyers secure the necessary funding for their purchases. Additionally, the company offers title insurance policies, as well as examination and closing services, to ensure a smooth transaction process. D.R. Horton is also involved in the residential lot development business, further expanding its reach within the real estate sector.
The company's business portfolio is diversified, with investments in multi-family and single-family rental properties. It develops, constructs, owns, leases, and sells these properties, catering to a broader range of customers beyond traditional homebuyers. Moreover, D.R. Horton has a presence in non-residential real estate, including the ownership of ranch land and improvements. Founded in 1978, the company is headquartered in Arlington, Texas, and is publicly traded on the New York Stock Exchange under the ticker symbol NYSE:DHI.
As a common stock listed under the ISIN US23331A1097, D.R. Horton, Inc. falls within the Homebuilding sub-industry according to the Global Industry Classification Standard (GICS). This classification reflects the company's primary focus on constructing and selling homes. With a well-established website at https://www.drhorton.com, D.R. Horton maintains a strong online presence, providing potential customers and investors with easy access to information about its services, products, and corporate activities.
Additional Sources for DHI Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DHI Stock Overview
Market Cap in USD | 44,884m |
Sector | Consumer Cyclical |
Industry | Residential Construction |
GiC Sub-Industry | Homebuilding |
IPO / Inception | 1992-06-05 |
DHI Stock Ratings
Growth 5y | 78.2% |
Fundamental | 53.8% |
Dividend | 59.0% |
Rel. Strength Industry | -231 |
Analysts | 3.59/5 |
Fair Price Momentum | 130.57 USD |
Fair Price DCF | 167.09 USD |
DHI Dividends
Dividend Yield 12m | 0.95% |
Yield on Cost 5y | 2.55% |
Annual Growth 5y | 12.39% |
Payout Consistency | 82.9% |
DHI Growth Ratios
Growth Correlation 3m | -93.1% |
Growth Correlation 12m | 36.5% |
Growth Correlation 5y | 87.2% |
CAGR 5y | 21.75% |
CAGR/Mean DD 5y | 1.65 |
Sharpe Ratio 12m | -0.33 |
Alpha | -41.05 |
Beta | 1.34 |
Volatility | 34.27% |
Current Volume | 3523.4k |
Average Volume 20d | 3221.7k |
As of January 12, 2025, the stock is trading at USD 136.52 with a total of 3,523,432 shares traded.
Over the past week, the price has changed by -2.41%, over one month by -13.04%, over three months by -25.38% and over the past year by -10.92%.
Partly, yes. Based on ValueRay Fundamental Analyses, DR Horton (NYSE:DHI) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.80 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DHI as of January 2025 is 130.57. This means that DHI is currently overvalued and has a potential downside of -4.36%.
DR Horton has received a consensus analysts rating of 3.59. Therefor, it is recommend to hold DHI.
- Strong Buy: 7
- Buy: 2
- Hold: 10
- Sell: 3
- Strong Sell: 0
According to ValueRays Forecast Model, DHI DR Horton will be worth about 144.3 in January 2026. The stock is currently trading at 136.52. This means that the stock has a potential upside of +5.71%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 178.2 | 30.5% |
Analysts Target Price | 180.9 | 32.5% |
ValueRay Target Price | 144.3 | 5.7% |